Chemotherapy News and Research

Latest Chemotherapy News and Research

Chemotherapy drug bortezomib packs a one-two punch

Chemotherapy drug bortezomib packs a one-two punch

Researchers discover markers that identify breast cancer subtypes resistant to Herceptin

Researchers discover markers that identify breast cancer subtypes resistant to Herceptin

Avastin slows growth of gliomas

Avastin slows growth of gliomas

Cancer is a stem cell issue

Cancer is a stem cell issue

Group exercise helps breast cancer sufferers

Group exercise helps breast cancer sufferers

Tea tree oil can lead to antibiotic resistance

Tea tree oil can lead to antibiotic resistance

HIV protein TAT used to pull protein Bim into cancer cells - helps kill cancer cells

HIV protein TAT used to pull protein Bim into cancer cells - helps kill cancer cells

New oral blood thinner

New oral blood thinner

New breast cancer drug Exemestane shows great potential to save lives

New breast cancer drug Exemestane shows great potential to save lives

Changes in breast cancer management

Changes in breast cancer management

Rate of stem cell transplants among African-Americans lower

Rate of stem cell transplants among African-Americans lower

New test shows which breast cancers will recur

New test shows which breast cancers will recur

Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus

Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus

Potential new cancer fighting drug found by mistake

Potential new cancer fighting drug found by mistake

Researchers identify human pancreatic cancer stem cells

Researchers identify human pancreatic cancer stem cells

Study finds flaws in cancer trials

Study finds flaws in cancer trials

Seed implants critical for achieving a better prostate cancer outcome

Seed implants critical for achieving a better prostate cancer outcome

Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women

Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women

Drug giant Wyeth loses another HRT trial to the tune of $1.5 million

Drug giant Wyeth loses another HRT trial to the tune of $1.5 million

Asentar for prostate cancer, a potential blockbuster

Asentar for prostate cancer, a potential blockbuster

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.